Literature DB >> 9845098

Redox generation of nitric oxide to radiosensitize hypoxic cells.

J B Mitchell1, W DeGraff, S Kim, J A Cook, J Gamson, D Christodoulou, M Feelisch, D A Wink.   

Abstract

PURPOSE: Previous studies have shown that nitric oxide (NO) delivered from NO donor agents sensitizes hypoxic cells to ionizing radiation. In the present study, nitroxyl (NO-), a potential precursor to endogenous NO production, was evaluated for hypoxic cell radiosensitization, either alone or in combination with electron acceptor agents. METHODS AND MATERIALS: Radiation survival curves of Chinese hamster V79 lung fibroblasts under aerobic and hypoxic conditions were assessed by clonogenic assay. Hypoxia induction was achieved by metabolism-mediated oxygen depletion in dense cell suspensions. Cells were treated with NO- produced from the nitroxyl donor Angeli's salt (AS, Na2N2O3, sodium trioxodinitrate), in the absence or presence of electron acceptor agents, ferricyanide, or tempol. NO concentrations resulting from the combination of AS and ferricyanide or tempol were measured under hypoxic conditions using an NO-sensitive electrode.
RESULTS: Treatment of V79 cells under hypoxic conditions with AS alone did not result in radiosensitization; however, the combination of AS with ferricyanide or tempol resulted in significant hypoxic radiosensitization with SERs of 2.5 and 2.1, respectively. Neither AS alone nor AS in combination with ferricyanide or tempol influenced aerobic radiosensitivity. The presence of NO generated under hypoxic conditions from the combination of AS with ferricyanide or tempol was confirmed using an NO-sensitive electrode.
CONCLUSION: Combining NO- generated from AS with electron acceptors results in NO generation and substantial hypoxic cell radiosensitization. NO- derived from donor agents or endogenously produced in tumors, combined with electron acceptors, may provide an important strategy for radiosensitizing hypoxic cells and warrants in vivo evaluation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845098     DOI: 10.1016/s0360-3016(98)00327-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production.

Authors:  Xiaoli Li; Dan Liu; Xin Liu; Weiwei Jiang; Weiying Zhou; Wei Yan; Yanyan Cen; Bin Li; Guanqun Cao; Guofu Ding; Xueli Pang; Jianguo Sun; Jiang Zheng; Hong Zhou
Journal:  Tumour Biol       Date:  2012-06-28

Review 2.  Links between innate immunity and normal tissue radiobiology.

Authors:  Dörthe Schaue; William H McBride
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

3.  Calpain mediates a von Hippel-Lindau protein-independent destruction of hypoxia-inducible factor-1alpha.

Authors:  Jie Zhou; Roman Köhl; Barbara Herr; Ronald Frank; Bernhard Brüne
Journal:  Mol Biol Cell       Date:  2006-01-18       Impact factor: 4.138

4.  JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.

Authors:  Astrid Weyerbrock; Nadja Osterberg; Nikolaos Psarras; Brunhilde Baumer; Evangelos Kogias; Anna Werres; Stefanie Bette; Joseph E Saavedra; Larry K Keefer; Anna Papazoglou
Journal:  Neurosurgery       Date:  2012-02       Impact factor: 4.654

5.  Suberoylanilide hydroxamic acid radiosensitizes tumor hypoxic cells in vitro through the oxidation of nitroxyl to nitric oxide.

Authors:  Yuval Samuni; David A Wink; Murali C Krishna; James B Mitchell; Sara Goldstein
Journal:  Free Radic Biol Med       Date:  2014-05-28       Impact factor: 7.376

6.  Reversible inactivation of dihydrolipoamide dehydrogenase by Angeli's salt.

Authors:  Liang-Jun Yan; Li Liu; Michael J Forster
Journal:  Sheng Wu Wu Li Hsueh Bao       Date:  2012-04-20

Review 7.  NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001.

Authors:  Jan Scicinski; Bryan Oronsky; Shoucheng Ning; Susan Knox; Donna Peehl; Michelle M Kim; Peter Langecker; Gary Fanger
Journal:  Redox Biol       Date:  2015-07-02       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.